|
EXE-346 Probiotic Clinical Trials
1 actively recruiting trial across 1 location
Also known as: EXE-346 Probiotic formula, Probiotic
Pipeline
Phase 2: 1
Top Sponsors
- University of California, San Francisco1
Indications
- Anal HSIL1
- HSIL, High Grade Squamous Intraepithelial Lesion1
- HPV-Related Squamous Cell Carcinoma1
- Cancer1
San Francisco, California1 trial
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
University of California, San Francisco
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.